Enovis Revenue and Competitors
Estimated Revenue & Valuation
- Enovis's estimated annual revenue is currently $15M per year.
- Enovis's estimated revenue per employee is $12,325
Employee Data
- Enovis has 1217 Employees.
- Enovis grew their employee count by 12% last year.
Enovis's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Chief Commercial Officer (CCO) | Reveal Email/Phone |
3 | VP | Reveal Email/Phone |
4 | VP | Reveal Email/Phone |
5 | Chief Operating Officer | Reveal Email/Phone |
6 | Head Operations | Reveal Email/Phone |
7 | VP Finance | Reveal Email/Phone |
8 | VP, Chief Counsel - Securities, Governance, M&A and Corporate Secretary | Reveal Email/Phone |
9 | VP Manufacturing | Reveal Email/Phone |
10 | VP, Regional General Manager Northern Europe | Reveal Email/Phone |
Enovis Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $7.3M | 34 | 0% | N/A | N/A |
#2 | $79.3M | 207 | -3% | N/A | N/A |
#3 | $137.7M | 408 | 23% | N/A | N/A |
#4 | $6.9M | 32 | N/A | N/A | N/A |
#5 | $145.5M | 431 | 19% | N/A | N/A |
#6 | $49.3M | 166 | 1% | N/A | N/A |
#7 | $1.1M | 8 | 60% | N/A | N/A |
#8 | $36.2M | 134 | 17% | N/A | N/A |
#9 | $4.2M | 22 | -31% | N/A | N/A |
#10 | $22.4M | 64 | 45% | N/A | N/A |
What Is Enovis?
Enovis™ is a medical technology company focused on developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, extraordinary talent and innovation, we ‘create better together’ by partnering with healthcare professionals. Our extensive range of products, services and integrated technologies fuel active lifestyles.
keywords:N/AN/A
Total Funding
1217
Number of Employees
$15M
Revenue (est)
12%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $423.3M | 1229 | 7% | N/A |
#2 | $253.3M | 1248 | 20% | N/A |
#3 | $543.6M | 1438 | N/A | N/A |
#4 | $444.1M | 1442 | -2% | N/A |
#5 | $549.6M | 1454 | 69% | N/A |